Effect of the anti-IL-17 antibody on allergic inflammation in an obesity-related asthma model
1
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Background/Aims: The co-occurrence of obesity aggravates asthma symptoms. Diet-induced obesity increases helper T cell (TH) 17 cell differentiation in adipose tissue and the spleen. The 3-hydroxy-3-methylglutaryl-coenzyme A reductase inhibitor pravastatin can potentially be used to treat asthma in obese patients by inhibiting interleukin 17 (IL-17) expression. This study investigated the combined effects of pravastatin and anti-IL-17 antibody treatment on allergic inflammation in a mouse model of obesity-related asthma. Methods: High-fat diet (HFD)-induced obesity was induced in C57BL/6 mice with or without ovalbumin (OVA) sensitization and challenge. Mice were administered the anti-IL-17 antibody, pravastatin, or both, and pathophysiological and immunological responses were analyzed. Results: HFD exacerbated allergic airway inflammation in the bronchoalveolar lavage fluid of HFD-OVA mice as compared to OVA mice. Blockading of the IL-17 in the HFD-OVA mice decreased airway hyper-responsiveness (AHR) and airway inflammation compared to the HFD-OVA mice. Moreover, the administration of the anti-IL-17 antibody decreased the leptin/adiponectin ratio in the HFD-OVA but not the OVA mice. Co-administration of pravastatin and anti-IL-17 inhibited airway inflammation and AHR, decreased goblet cell numbers, and increased adipokine levels in obese asthmatic mice. Conclusions: These results suggest that the IL-17–leptin/adiponectin axis plays a key role in airway inflammation in obesity-related asthma. Our findings suggest a potential new treatment for IL-17 as a target that may benefit obesity-related asthma patients who respond poorly to typical asthma medications.
Abstract
Background/Aims: The co-occurrence of obesity aggravates asthma symptoms. Diet-induced obesity increases helper T cell (TH) 17 cell differentiation in adipose tissue and the spleen. The 3-hydroxy-3-methylglutaryl-coenzyme A reductase inhibitor pravastatin can potentially be used to treat asthma in obese patients by inhibiting interleukin 17 (IL-17) expression. This study investigated the combined effects of pravastatin and anti-IL-17 antibody treatment on allergic inflammation in a mouse model of obesity-related asthma. Methods: High-fat diet (HFD)-induced obesity was induced in C57BL/6 mice with or without ovalbumin (OVA) sensitization and challenge. Mice were administered the anti-IL-17 antibody, pravastatin, or both, and pathophysiological and immunological responses were analyzed. Results: HFD exacerbated allergic airway inflammation in the bronchoalveolar lavage fluid of HFD-OVA mice as compared to OVA mice. Blockading of the IL-17 in the HFD-OVA mice decreased airway hyper-responsiveness (AHR) and airway inflammation compared to the HFD-OVA mice. Moreover, the administration of the anti-IL-17 antibody decreased the leptin/adiponectin ratio in the HFD-OVA but not the OVA mice. Co-administration of pravastatin and anti-IL-17 inhibited airway inflammation and AHR, decreased goblet cell numbers, and increased adipokine levels in obese asthmatic mice. Conclusions: These results suggest that the IL-17–leptin/adiponectin axis plays a key role in airway inflammation in obesity-related asthma. Our findings suggest a potential new treatment for IL-17 as a target that may benefit obesity-related asthma patients who respond poorly to typical asthma medications.
참고문헌 (40)
- Bastard JP, "Recent advances in the relationship between obesity, inflammation, and insulin resistance", Eur Cytokine Netw, 17, pp.4~12 (2006)
- Olin JT, "Asthma: pathogenesis and novel drugs for treatment", BMJ, 349, pp.g5517~ (2014)
- Muc M, "Association between obesity and asthma: epidemiology, pathophysiology and clinical profile", Nutr Res Rev, 29, pp.194~201 (2016)
- Delgado J, "Obesity and asthma", J Investig Allergol Clin Immunol, 18, pp.420~425 (2008)
- King GG, "The effects of body weight on airway calibre", Eur Respir J, 25, pp.896~901 (2005)
- Calixto MC, "Obesity enhances eosinophilic inflammation in a murine model of allergic asthma", Br J Pharmacol, 159, pp.617~625 (2010)
- Lintomen L, "Allergen-induced bone marrow eosinophilopoiesis and airways eosinophilic inflammation in leptin-deficient ob", ob mice, 2012, pp.20, 1959~1965
- Baffi CW, "Asthma and obesity:mechanisms and clinical implications", Asthma Res Pract, 1, pp.1~ (2015)
- Wenzel SE, "Asthma phenotypes: the evolution from clinical to molecular approaches", Nat Med, 18, pp.716~725 (2012)
- Endo Y, "The obesity-related pathology and Th17 cells", Cell Mol Life Sci, 74, pp.1231~1245 (2017)
- Leiria LO, "Obesity and asthma: beyond T(H)2 inflammation", Metabolism, 64, pp.172~181 (2015)
- Kim HY, "Interleukin-17-producing innate lymphoid cells and the NLRP3 inflammasome facilitate obesity-associated airway hyperreactivity", Nat Med, 20, pp.54~61 (2014)
- Kudo M, "IL-17A produced by αβT cells drives airway hyper-responsiveness in mice and enhances mouse and human airway smooth muscle contraction", Nat Med, 18, pp.547~554 (2012)
- Agache I, "Increased serum IL-17 is an independent risk factor for severe asthma", Respir Med, 104, pp.1131~1137 (2010)
- Wang CY, "Pleiotropic effects of statin therapy: molecular mechanisms and clinical results", Trends Mol Med, 14, pp.37~44 (2008)
- Zhang X, "Statins' immunomodulatory potential against Th17 cell-mediated autoimmune response", Immunol Res, 41, pp.165~174 (2008)
- Youssef S, "The HMG-CoA reductase inhibitor, atorvastatin, promotes a Th2 bias and reverses paralysis in central nervous system autoimmune disease", Nature, 420, pp.78~84 (2002)
- Imamura M, "Pravastatin attenuates allergic airway inflammation by suppressing antigen sensitisation, interleukin 17 production and antigen presentation in the lung", Thorax, 64, pp.44~49 (2009)
- Celedon JC, "An innate link between obesity and asthma", Nat Med, 20, pp.19~20 (2014)
- Mraz M, "The role of adipose tissue immune cells in obesity and low-grade inflammation", J Endocrinol, 222, pp.R113~R127 (2014)
- Zarkesh-Esfahani H, "Leptin indirectly activates human neutrophils via induction of TNF-alpha", J Immunol, 172, pp.1809~1814 (2004)
- Kato H, "Leptin has a priming effect on eotaxin-induced human eosinophil chemotaxis", Int Arch Allergy Immunol, 155, pp.335~344 (2011)
- McLachlan CR, "Adiposity, asthma, and airway inflammation", J Allergy Clin Immunol, 119, pp.634~639 (2007)
- Holguin F, "Obesity and asthma: an association modified by age of asthma onset", J Allergy Clin Immunol, 127, pp.1486~1493 (2011)
- Wu D, "Eosinophils sustain adipose alternatively activated macrophages associated with glucose homeostasis", Science, 332, pp.243~247 (2011)
- Ignacio RM, "Immunological profiling of obesity", J Lifestyle Med, 4, pp.1~7 (2014)
- Lord G., "Role of leptin in immunology", Nutr Rev, 60(10Pt 2), pp.S35~S38 (2002)
- Brestoff JR, "Group 2 innate lymphoid cells promote beiging of white adipose tissue and limit obesity", Nature, 519, pp.242~246 (2015)
- Lumeng CN, "Obesity induces a phenotypic switch in adipose tissue macrophage polarization", J Clin Invest, 117, pp.175~184 (2007)
- Sumarac-Dumanovic M, "Increased activity of interleukin-23", interleukin-17 proinflammatory axis in obese women, 2009, pp.33, 151~156
- Zuniga LA, "IL-17 regulates adipogenesis, glucose homeostasis, and obesity", J Immunol, 185, pp.6947~6959 (2010)
- Litonjua AA, "Asthma and obesity: common early-life influences in the inception of disease", J Allergy Clin Immunol, 121, pp.1075~1084 (2008)
- Sood A, "Association between leptin and asthma in adults", Thorax, 61, pp.300~305 (2006)
- Schachter LM, "Obesity is a risk for asthma and wheeze but not airway hyperresponsiveness", Thorax, 56, pp.4~8 (2001)
- Bustos P, "Is there a causal relation between obesity and asthma? Evidence from Chile", Int J Obes (Lond), 29, pp.804~809 (2005)
- Barlow JL, "Reciprocal expression of IL-25 and IL-17A is important for allergic airways hyperreactivity", Clin Exp Allergy, 41, pp.1447~1455 (2011)
- Schnyder-Candrian S, "Interleu kin-17 is a negative regulator of established allergic asthma", J Exp Med, 203, pp.2715~2725 (2006)
- Jartti T, "Obesity, adipokines and asthma", Allergy, 64, pp.770~777 (2009)
- Jang AS, "Association of serum leptin and adiponectin with obesity in asthmatics", J Asthma, 46, pp.59~63 (2009)
- Song C, "IL-17-producing alveolar macrophages mediate allergic lung inflammation related to asthma", J Immunol, 181, pp.6117~6124 (2008)